Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Return on Invested Capital (2022)

Historic Return on Invested Capital for Atea Pharmaceuticals (AVIR) over the last 2 years, with Q3 2022 value amounting to 0.05%.

  • Atea Pharmaceuticals' Return on Invested Capital changed 0.0% to 0.05% in Q3 2022 from the same period last year, while for Sep 2022 it was 0.05%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.19% for FY2021, which is N/A changed from last year.
  • Atea Pharmaceuticals' Return on Invested Capital amounted to 0.05% in Q3 2022, which was down 0.0% from 0.02% recorded in Q2 2022.
  • In the past 5 years, Atea Pharmaceuticals' Return on Invested Capital ranged from a high of 0.19% in Q4 2021 and a low of 0.02% during Q2 2022